DMAQ

Investor Moves

Investor	Portfolio Value	Portfolio Change	Position Change	Avg Buy Price	Current Price
Jim SimonsRenaissance Technologies $-11.9K ExitQ1 2025 $12k -- --

Trade DMAQ

About Deep Medicine Acquisition Corp.

Deep Medicine Acquisition Corp. (DMAQ) currently operates as a non-operating entity, possessing no substantial business functions of its own. Its express purpose is to execute a business combination, which could entail a merger, an acquisition of equity or assets, or a reorganization, with one or more target companies. The firm's strategic efforts are specifically concentrated on identifying promising enterprises within the healthcare industry. Incorporated in 2020, DMAQ maintains its principal place of business in New York, New York.

CEO: Humphrey P. Polanen
IPO Date: Dec 2, 2021

Market Data

Open: $7.54
High: $7.69
Low: $2.96
Volume: 73.9K
52W High: $19.91
52W Low: $2.96

Valuation

Market Cap: $13M
Enterprise Value: $-2.5M

Financials

Free Cash Flow: $-1.9M
Revenue: $19M
Net Income: $-15M
Cash: $10M
Debt: $5.9M

Events

EarningsSep 30

actual -0.06156